Myths & Facts: Autism
Dispelling the myths surrounding this condition can help parents and caregivers support individuals with ASD, as well as clear up stereotypes and misunderstandings often associated with it.
A Primer on Mpox
Most human cases of this zoonotic virus are mild, but knowing the signs, symptoms and preventive measures for transmitting this disease remains important for public health.
Update on Toxoplasmosis
Because there is no cure or vaccine for this widespread parasitic infection, knowing how toxoplasmosis is spread and best practices for preventing transmission remains important.
Study Finds IVIG Effective for Treating Dermatomyositis
A study evaluating intravenous immune globulin for the treatment of dermatomyositis has found it significantly improved patient outcomes.
Regen BioPharma Files Patent for mRNA Cancer Vaccine
Regen BioPharma has filed a provisional patent application covering utilization of dendritic cell technologies to augment efficacy of its patented mRNA cancer immunotherapeutic vaccine.
First Malaria Vaccine Prequalified by WHO
The World Health Organization has prequalified the first malaria vaccine, RTS,S/AS01 (also known as Mosquirix), manufactured by GSK, bringing it closer to reaching millions more children at risk of malaria.
TIL Therapy Found More Effective for Metastatic Melanoma Than Current Treatments
A Phase III clinical trial has found tumor-infiltrating lymphocyte therapy, a new treatment for advanced melanoma, was more effective than ipilimumab, the lading existing therapy.
Researchers Develop a New mRNA Vaccine to Treat Cancer
U.S. researchers have developed a new mRNA vaccine against cancer that delivers the drug directly to the lymphatic system and simulates a strong immune response.
Study Finds Pfizer’s RSV Vaccine Effective in Preventing Illness in Older Adults
Results of a recent study shows Pfizer’s experimental vaccine for respiratory syncytial virus is nearly 86 percent effective in preventing severe illness in older adults.
Experimental RSV Vaccine Shows Promise in Mice
An experimental vaccine shows promise for protecting mice from the respiratory syncytial virus, the pathogen that most commonly causes the chest infection bronchiolitis in young children.